Sarah D. Cramer Cytokines and Immunity Section, Cancer Innovation Laboratory, National Cancer Institute National Institutes of Health Biography Publications Institution JoVE Articles Sarah D. Cramer has not added a biography. If you are Sarah D. Cramer and would like to personalize this page please email our Author Liaison for assistance. Publications Mutations That Collaborate with IL-7Ra Signaling Pathways to Drive ALL Advances in Biological Regulation. May, 2021 | Pubmed ID: 33578108 Agreement in Histological Assessment of Mitotic Activity Between Microscopy and Digital Whole Slide Images Informs Conversion for Clinical Diagnosis Academic Pathology. 2019 | Pubmed ID: 31321298 Inhibiting Janus Kinase 1 and BCL-2 to Treat T Cell Acute Lymphoblastic Leukemia with IL7-Rα Mutations Oncotarget. Apr, 2018 | Pubmed ID: 29854301 Plasticity in Early Immune Evasion Strategies of a Bacterial Pathogen Proceedings of the National Academy of Sciences of the United States of America. 04, 2018 | Pubmed ID: 29610317 Mutant IL-7Rα and Mutant NRas Are Sufficient to Induce Murine T Cell Acute Lymphoblastic Leukemia Leukemia. Aug, 2018 | Pubmed ID: 29535426 Therapeutic Targeting of IL-7Rα Signaling Pathways in ALL Treatment Blood. Jul, 2016 | Pubmed ID: 27268088 Совместное культивирование и трансдукция мышиных тимоцитов на дельта-подобных 4-экспрессирующих стромальных клетках для изучения онкогенов при Т-клеточном лейкозе Gisele O. L. Rodrigues1, WenQing Li1, Sarah D. Cramer1,2,3, Hila Y. Winer1, Tu Chun Hsu1,2,3, Timothy Gower4, Julie A. Hixon1, Scott K. Durum1 1Cytokines and Immunity Section, Cancer Innovation Laboratory, National Cancer Institute, National Institutes of Health, 2Comparative Biomedical Scientist Training Program, NIH, 3Department of Pathobiology and Diagnostic Investigation, Veterinary Diagnostic Laboratory, Michigan State University, 4NCI-Frederick Laboratory Animal Sciences Program JoVE 64271 Cancer Research
Совместное культивирование и трансдукция мышиных тимоцитов на дельта-подобных 4-экспрессирующих стромальных клетках для изучения онкогенов при Т-клеточном лейкозе Gisele O. L. Rodrigues1, WenQing Li1, Sarah D. Cramer1,2,3, Hila Y. Winer1, Tu Chun Hsu1,2,3, Timothy Gower4, Julie A. Hixon1, Scott K. Durum1 1Cytokines and Immunity Section, Cancer Innovation Laboratory, National Cancer Institute, National Institutes of Health, 2Comparative Biomedical Scientist Training Program, NIH, 3Department of Pathobiology and Diagnostic Investigation, Veterinary Diagnostic Laboratory, Michigan State University, 4NCI-Frederick Laboratory Animal Sciences Program JoVE 64271 Cancer Research